Chang, T.; Ho, H.-L.; Hsu, S.-J.; Chang, C.-C.; Tsai, M.-H.; Huo, T.-I.; Huang, H.-C.; Lee, F.-Y.; Hou, M.-C.; Lee, S.-D.
Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. Int. J. Mol. Sci. 2019, 20, 4161.
https://doi.org/10.3390/ijms20174161
AMA Style
Chang T, Ho H-L, Hsu S-J, Chang C-C, Tsai M-H, Huo T-I, Huang H-C, Lee F-Y, Hou M-C, Lee S-D.
Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. International Journal of Molecular Sciences. 2019; 20(17):4161.
https://doi.org/10.3390/ijms20174161
Chicago/Turabian Style
Chang, Ting, Hsin-Ling Ho, Shao-Jung Hsu, Ching-Chih Chang, Ming-Hung Tsai, Teh-Ia Huo, Hui-Chun Huang, Fa-Yauh Lee, Ming-Chih Hou, and Shou-Dong Lee.
2019. "Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats" International Journal of Molecular Sciences 20, no. 17: 4161.
https://doi.org/10.3390/ijms20174161
APA Style
Chang, T., Ho, H.-L., Hsu, S.-J., Chang, C.-C., Tsai, M.-H., Huo, T.-I., Huang, H.-C., Lee, F.-Y., Hou, M.-C., & Lee, S.-D.
(2019). Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. International Journal of Molecular Sciences, 20(17), 4161.
https://doi.org/10.3390/ijms20174161
